Intravenous P2Y12 receptor inhibitor – Cardiology MCQ

Intravenous P2Y12 receptor inhibitor:
a) Ticagrelor
b) Clopidogrel
c) Prasugrel
d) Cangrelor
Correct answer: d) Cangrelor
Cangrelor is a reversible intravenous P2Y12 receptor inhibitor. It is a rapid and potent inhibitor of ADP induced platelet aggregation. Its plasma half life is less than 10 minutes and platelet function is restored within 2 hours of discontinuation of infusion.